Osaic Holdings’s Anixa Biosciences ANIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$129 Hold
50
﹤0.01% 7602
2025
Q4
$156 Hold
50
﹤0.01% 7604
2025
Q3
$149 Hold
50
﹤0.01% 7723
2025
Q2
$165 Buy
50
+30
+150% +$86 ﹤0.01% 7526
2025
Q1
$57 Sell
20
-304
-94% -$869 ﹤0.01% 7276
2024
Q4
$751 Sell
324
-1,076
-77% -$3.34K ﹤0.01% 6914
2024
Q3
$4.41K Hold
1,400
﹤0.01% 6271
2024
Q2
$3.09K Hold
1,400
﹤0.01% 6413
2024
Q1
$4.37K Buy
1,400
+1,000
+250% +$3.99K ﹤0.01% 6152
2023
Q4
$1.55K Hold
400
﹤0.01% 6621
2023
Q3
$1.31K Hold
400
﹤0.01% 6758
2023
Q2
$1.28K Hold
400
﹤0.01% 6808
2023
Q1
$1.72K Sell
400
-500
-56% -$2.19K ﹤0.01% 6778
2022
Q4
$4K Sell
900
-100
-10% -$481 ﹤0.01% 6368
2022
Q3
$4K Sell
1,000
-900
-47% -$3.65K ﹤0.01% 6453
2022
Q2
$6K Buy
1,900
+500
+36% +$1.58K ﹤0.01% 6365
2022
Q1
$4K Sell
1,400
-500
-26% -$1.47K ﹤0.01% 6563
2021
Q4
$6K Sell
1,900
-2,000
-51% -$8.09K ﹤0.01% 6519
2021
Q3
$19K Hold
3,900
﹤0.01% 5805
2021
Q2
$15K Hold
3,900
﹤0.01% 5814
2021
Q1
$18K Buy
3,900
+2,900
+290% +$13.9K ﹤0.01% 5543
2020
Q4
$3K Buy
+1,000
New +$2.51K ﹤0.01% 5915

Other funds holding ANIX

Osaic Holdings's ANIX Position: Q1 2026 in Review

Osaic Holdings held its Anixa Biosciences (ANIX) position steady in Q1 2026 at 50 shares worth $129. The position accounts for ﹤0.01% of the portfolio, ranked #7602.

Osaic Holdings first reported a position in ANIX in Q4 2020 and has held it in 22 quarters since. The position peaked at $19K in Q3 2021. 60 funds tracked by Wall St. Rank hold ANIX as of Q1 2026.

  • Osaic Holdings held 50 shares of Anixa Biosciences worth $129 as of Q1 2026.
  • Osaic Holdings left its Anixa Biosciences share count unchanged in Q1 2026.
  • Anixa Biosciences made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #7602 holding.
  • Osaic Holdings first reported a position in Anixa Biosciences in Q4 2020 and has held it in 22 quarters since.
  • Osaic Holdings's Anixa Biosciences position peaked at $19K in Q3 2021.
  • 60 funds tracked by Wall St. Rank held Anixa Biosciences as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.